SRTS
Sensus Healthcare, Inc
stockNASDAQ
sensus healthcare, inc. is a medical device company that is committed to enabling non-invasive and cost-effective treatment of non-melanoma skin cancer and keloids. sensus uses a proprietary low energy x-ray radiation technology known as superficial radiation therapy (srt), which is a result of over a decade of dedicated research and development activities. sensus has successfully incorporated the srt therapy into its portfolio of treatment devices: srt-100™ and srt-100 vision™. srt technology effectively and safely treats oncological and non-oncological skin conditions. for more information, visit http://www.sensushealthcare.com.
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 2.79 | 2026-10-27 | +25.09% | 0.450 |
| 1M | 2.98 | 2026-10-02 | +17.11% | -0.336 |
| 3M | 2.92 | 2026-08-03 | +19.52% | 0.265 |
| 6M | 3.96 | 2026-05-04 | -11.87% | 0.082 |
| 1Y | 3.10 | 2025-11-03 | +12.58% | 0.857 |
| 2Y | 6.36 | 2024-11-04 | -45.13% | — |
| 5Y | 4.04 | 2021-11-03 | -13.62% | 0.929 |
Sensus Healthcare, Inc (NASDAQ:SRTS) stock price today is $3.49, and today's volume is 8,719,324. SRTS is up 26.905% today. The 30 day average volume is 25,620. SRTS market cap is $57.45M with 16.46M shares outstanding.